Literature DB >> 14872146

Abdominal aortic aneurysm.

L Michael Prisant1, J Sheppard Mondy.   

Abstract

An abdominal aortic aneurysm (AAA) is defined as a localized dilation of the artery that is 1.5 times the diameter of the normal segment. The most common location for an aortic aneurysm is the infrarenal segment where a diameter that exceeds 3 cm in diameter is considered aneurysmal. Duplex ultrasonography and spiral computerized tomography are the imaging modalities most commonly performed to detect the longitudinal and transverse diameter of the aorta. The prevalence of AAA may be increasing. Smoking, male gender, and increasing age are the most powerful predictors of AAA. Considering the higher prevalence of hypertension, it is surprising that the prevalence of AAA among African-American men is 39% less than white men. The risk of rupture is independently associated with female gender, large initial aneurysm diameter, lower forced expiratory volume in the first second, current smoking, and higher mean blood pressure. Inflammation rather than atherosclerosis may be essential to the development of AAA. Treatment is directed at smoking cessation and control of blood pressure and lipids. Beta blockers (propranolol) have not been shown to modify aneurysm growth rates, but drop out rates in the studies have been high. Antibiotics do show a modest benefit. Surgery is generally performed when the aneurysm exceeds 5.5 cm in men. For women, an AAA size between 4.5 cm and 5.0 cm is recommended for elective repair.

Entities:  

Mesh:

Year:  2004        PMID: 14872146      PMCID: PMC8109332          DOI: 10.1111/j.1524-6175.2004.02838.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

1.  Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.

Authors:  M Mosorin; J Juvonen; F Biancari; J Satta; H M Surcel; M Leinonen; P Saikku; T Juvonen
Journal:  J Vasc Surg       Date:  2001-10       Impact factor: 4.268

2.  The rational clinical examination. Does this patient have abdominal aortic aneurysm? .

Authors:  F A Lederle; D L Simel
Journal:  JAMA       Date:  1999-01-06       Impact factor: 56.272

Review 3.  Abdominal aortic aneurysm.

Authors:  J A van der Vliet; A P Boll
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

4.  Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms.

Authors:  J S Lindholt; E W Henneberg; S Juul; H Fasting
Journal:  Int Angiol       Date:  1999-03       Impact factor: 2.789

5.  Risk factors for abdominal aortic aneurysm: results of a case-control study.

Authors:  J F Blanchard; H K Armenian; P P Friesen
Journal:  Am J Epidemiol       Date:  2000-03-15       Impact factor: 4.897

Review 6.  Abdominal aortic aneurysm.

Authors:  C B Ernst
Journal:  N Engl J Med       Date:  1993-04-22       Impact factor: 91.245

7.  Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group.

Authors:  F A Lederle; G R Johnson; S E Wilson; E P Chute; F N Littooy; D Bandyk; W C Krupski; G W Barone; C W Acher; D J Ballard
Journal:  Ann Intern Med       Date:  1997-03-15       Impact factor: 25.391

Review 8.  Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery.

Authors:  David C Brewster; Jack L Cronenwett; John W Hallett; K Wayne Johnston; William C Krupski; Jon S Matsumura
Journal:  J Vasc Surg       Date:  2003-05       Impact factor: 4.268

9.  Variability in measurement of abdominal aortic aneurysms. Abdominal Aortic Aneurysm Detection and Management Veterans Administration Cooperative Study Group.

Authors:  F A Lederle; S E Wilson; G R Johnson; D B Reinke; F N Littooy; C W Acher; L M Messina; D J Ballard; H J Ansel
Journal:  J Vasc Surg       Date:  1995-06       Impact factor: 4.268

10.  Epidemiology of aortic aneurysm in the United States.

Authors:  R F Gillum
Journal:  J Clin Epidemiol       Date:  1995-11       Impact factor: 6.437

View more
  4 in total

1.  Mechanisms underlying the inhibitory effects of probucol on elastase-induced abdominal aortic aneurysm in mice.

Authors:  Cong Chen; Yunxia Wang; Yini Cao; Qinyu Wang; Gulinigaer Anwaier; Qingyi Zhang; Rong Qi
Journal:  Br J Pharmacol       Date:  2019-11-03       Impact factor: 8.739

2.  Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice.

Authors:  F Jiang; G T Jones; G J Dusting
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

3.  Influence of Selective Biochemical and Morphological Agents on Natural History of Aneurysm of Abdominal Aorta Development.

Authors:  Tomasz Wołoszko; Maciej Skórski; Przemysław Kwasiborski; Ewelina Kmin; Zbigniew Gałązka; Ryszard Pogorzelski
Journal:  Med Sci Monit       Date:  2016-02-09

4.  Ophthalmoscopic findings in malignant hypertension.

Authors:  Stephen Hammond; Jill Razor Wells; Dennis M Marcus; L Michael Prisant
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-03       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.